For research use only. We do not sell to patients.
PARP-1/HDAC-IN-1
Biological Activity:PARP-1/HDAC-IN-1 is a PARP-1/HDAC6 dual targeting inhibitor with IC50s of 68.90 nM and 510 nM, respectively. PARP-1/HDAC-IN-1 displays remarkable anticancer, anti-migration and anti-angiogenesis activities.
Research Area:Cancer
Targets:PARP|HDAC
Related Small Molecules:Rucaparib monocamsylate;AZD-2461;Senaparib;Pivanex;Dehydrocorydaline;Rucaparib hydrochloride;Crotonoside;MPT0B390;Niraparib tosylate;RSC133;HDAC1/6-IN-1;HDAC/HSP90-IN-4;JPS014;G007-LK;PROTAC PARP1 degrader;HDAC-IN-4;UPF 1069;HDAC-IN-27;1-Alaninechlamydocin;SKLB-23bb;Tacedinaline;HPOB;HDAC-IN-28;CG347B;Tubacin;HDAC10-IN-1;DP-C-4;HDAC6-IN-6;Resminostat
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Fluorescent Dye | PROTAC | Isotope-Labeled Compounds | Oligonucleotides
About Us:
- MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use;
- Structurally and synthetically diverse biologically active compounds;
- roduct quality is the key to our success and we take pride in offering only the highest-grade products.;
- We provide HNMR, LC-MS, HPLC, stability testing and activity assays of our products to clients.;
- Product identity, quality, purity and activity are assured by our robust quality control programs and procedures.;
- Customized order volume ranging from milligrams to kilograms scale;
Structurally and synthetically diverse biologically active compounds;
We provide customer-oriented services. To explore more, please contact us at [email protected]. Our team will gladly assist you.